| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/03/2007 | US20070099845 N-Acetyl L-Cysteine and L-Cysteine Choline Esters, and (R)-[2-(2,2-Dimethyl-thiazolidine-4-carbonyloxy)-ethyl]trimethyl-ammonium chloride, for example; compounds may be used to inhibit oxidative stress-induced cell injury or death both in vivo and ex vivo |
| 05/03/2007 | US20070099844 Novel methods for the treatment of cancer |
| 05/03/2007 | US20070099834 Compositions and methods related to anti-FGF agents |
| 05/03/2007 | US20070099832 Combination Therapy with p38 MAP Kinase Inhibitors and their Pharmaceutical Compositions |
| 05/03/2007 | US20070099831 Parathyroid hormone analogues and methods of use |
| 05/03/2007 | US20070099827 Sialogogue, oral composition and fool product containing the same |
| 05/03/2007 | US20070099826 Treatment of diseases associated with the egr-1 enhancer element |
| 05/03/2007 | US20070099823 Inhibitors of sporeforming pathogens and applications of the same |
| 05/03/2007 | US20070099271 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 05/03/2007 | US20070099237 Reaction co-crystallization of molecular complexes or co-crystals |
| 05/03/2007 | US20070099186 Methods and means for the treatment of disorders associated with cellular senescence |
| 05/03/2007 | US20070098843 Medicament sustained-release particles and method for preparing the same |
| 05/03/2007 | US20070098827 In vitro and in vivo anti-inflammatory effects of a sesquiterpene lactone extract from chicory (cichorium intybus l.) |
| 05/03/2007 | US20070098826 Use of pinitol or chiroinositol for protecting the liver |
| 05/03/2007 | US20070098820 Compositions containing cis-isomers of a carotenoid compound and process |
| 05/03/2007 | US20070098819 Micronutrient supplement with calcium, vitamin D or calcium & vitamin D combination for premenstrual syndrome, postpartum depression, depression and panic attacks |
| 05/03/2007 | US20070098818 Ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
| 05/03/2007 | US20070098816 Pharmaceutical composition containing histone deacetylase inhibitor |
| 05/03/2007 | US20070098815 Orally Administrable Gallium Compositions and Methods of Use |
| 05/03/2007 | US20070098812 Annexin II and uses thereof |
| 05/03/2007 | US20070098810 Preparation for solid calcium bolus product |
| 05/03/2007 | US20070098809 Therapeutic use of lipids extracted from mother of pearl |
| 05/03/2007 | US20070098808 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases arthritis, skin cancer diabetes, premenstrual syndrome and transdermal transport |
| 05/03/2007 | US20070098807 Matrices for drug delivery and methods for making and using the same |
| 05/03/2007 | US20070098805 Methods of making and using novel griseofulvin compositions |
| 05/03/2007 | US20070098804 Solid particulate tadalafil having a bimodal particle size distribution |
| 05/03/2007 | US20070098802 Organic nanoparticles and associated methods |
| 05/03/2007 | US20070098801 Particles shaped as platelets |
| 05/03/2007 | US20070098800 Therapeutic compositions |
| 05/03/2007 | US20070098796 Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochrloride |
| 05/03/2007 | US20070098795 Pharmaceutical formulation |
| 05/03/2007 | US20070098794 Oxymorphone controlled release formulations |
| 05/03/2007 | US20070098793 Oxymorphone controlled release formulations |
| 05/03/2007 | US20070098792 Oxymorphone controlled release formulations |
| 05/03/2007 | US20070098791 Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride |
| 05/03/2007 | US20070098790 Nutritional supplement for the enhancement of the health of the liver |
| 05/03/2007 | US20070098789 Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same |
| 05/03/2007 | US20070098788 Non-benzodiazepine hypnotic compositions |
| 05/03/2007 | US20070098787 Composition for preventing and treating varicose veins of lower extremities |
| 05/03/2007 | US20070098786 Enteric valproic acid |
| 05/03/2007 | US20070098782 Solid form; stabilized to control degradation to the active metabolite ramiprilat instead of ramipril diketopiperazine; hypertension, heart failure, stroke, myocardial infarction, diabetes and cardiovascular disease |
| 05/03/2007 | US20070098778 Co-formulations or kits of bioactive agents |
| 05/03/2007 | US20070098777 Pharmaceutical or Food Composition for Treatment or Prevention of Brain Edema |
| 05/03/2007 | US20070098775 Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels |
| 05/03/2007 | US20070098772 Transdermal norelgestromin delivery system |
| 05/03/2007 | US20070098769 Systems and methods for treating hot flashes associated with menopause |
| 05/03/2007 | US20070098765 Method of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof |
| 05/03/2007 | US20070098764 Colon cleansing compositions and methods |
| 05/03/2007 | US20070098763 Soluble Fiber Combinations for Weight Control and Improving Parameters of Cardiovascular Health |
| 05/03/2007 | US20070098762 Immunemodulating oligosaccharides |
| 05/03/2007 | US20070098761 Processed fat composition for preventing/ameliorating lifestyle-related diseases |
| 05/03/2007 | US20070098760 Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| 05/03/2007 | US20070098757 E-PTFE foil impregnated with an encapsulated bioactive substance |
| 05/03/2007 | US20070098753 Local administration of a combination of rapamycin and cilostazol for the treatment of vascular disease |
| 05/03/2007 | US20070098748 Stabilized Formulations of alpha Adrenergic Receptor Antagonists and the Uses Thereof |
| 05/03/2007 | US20070098747 Topical pharmaceutical composition for the treatment of inflammatory dermatoses |
| 05/03/2007 | US20070098740 Stabilisation of viral microparticles |
| 05/03/2007 | US20070098736 Injection vehicle for polymer-based formulations |
| 05/03/2007 | US20070098732 Immunologic compounds for prevention, protection, prophylaxis or treatment of immunological disorders, infections and cancer |
| 05/03/2007 | US20070098724 Methods of Treatment Using Vascular Occlusion in Combination with One or More Therapies |
| 05/03/2007 | US20070098713 Nanoparticle delivery systems and methods of use thereof |
| 05/03/2007 | US20070098709 Methods for treating and preventing diabetic retinopathy |
| 05/03/2007 | US20070098697 Adding to the blood to be transfused a photosensitizer comprising riboflavin, irradiating the blood and riboflavin with light, transfusing the irradiated blood into a recipient; preventing organ rejection; Transfusion Associated Graft vs. Host Disease |
| 05/03/2007 | US20070098693 Methods for enhancing engraftment of purified hematopoietic stem cells in allogenic recipients |
| 05/03/2007 | US20070098686 Use of apoptotic cells ex vivo to generate regulatory T Cells |
| 05/03/2007 | US20070098685 Methods and kits to treat chronic inflammatory immune diseases by administering a proteasome inhibitor and an interleukin 2 receptor agonist |
| 05/03/2007 | US20070098684 Methods of reducing aggregation of IL-1ra |
| 05/03/2007 | US20070098679 Methods and Compositions for Applying Pharmacologic Agents to the Ear |
| 05/03/2007 | US20070098678 Enteric coated aliphatic amine polymer bile acid sequestrants |
| 05/03/2007 | US20070098677 Ophthalmic compositions containing galactomannan polymers and borate |
| 05/03/2007 | US20070098676 Functionally diverse macromolecules and their synthesis |
| 05/03/2007 | US20070098675 Cross-linked polymer matrices, and methods of making and using same |
| 05/03/2007 | US20070098674 Compositions and methods for cell killing |
| 05/03/2007 | US20070098673 Antibacterial deodorizer kit for refrigerator and purifying system using the same |
| 05/03/2007 | US20070098649 Method and composition for controlling oral pathogens |
| 05/03/2007 | US20070098648 Treating mouth sores caused by dental braces with blobs of hydrophilic gums |
| 05/03/2007 | US20070098645 Intranasal delivery of compounds that reduce intrancranial pressure |
| 05/03/2007 | US20070098644 Delivery of a combination therapy for asthma and chronic obstructive pulmonary disease |
| 05/03/2007 | US20070098632 Analogs of terpene trilactones from ginkgo biloba and related compounds and uses thereof |
| 05/03/2007 | DE19940220B4 Medizinisches Präparat zur Behandlung von Arthrose, Arthritis und anderen rheumatischen Gelenkerkrankungen A medical preparation for the treatment of osteoarthritis, arthritis and other rheumatic joint diseases |
| 05/03/2007 | DE112005000725T5 Verfahren und Zusammensetzungen zur Behandlung von Ionen-Ungleichgewichten Methods and compositions for treatment of ion imbalance |
| 05/03/2007 | DE10333509B4 Gegen VEGF gerichtete Erkennungsmoleküle und die Verwendung dieser Directed against VEGF recognition molecules and the use of these |
| 05/03/2007 | DE102005052173A1 Fatty acid ester mixture, useful in cosmetic- and/or pharmaceutical preparation and as an oil-component comprises a mixture of 2-ethylhexanol and fatty acid |
| 05/03/2007 | DE102005052127A1 Neue indol-haltige Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New indol-containing beta-agonists, to processes for their preparation and their use as medicaments |
| 05/03/2007 | DE102005052103A1 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-agonists, to processes for their preparation and their use as medicaments |
| 05/03/2007 | DE102005052102A1 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-agonists, to processes for their preparation and their use as medicaments |
| 05/03/2007 | DE102005052101A1 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-agonists, to processes for their preparation and their use as medicaments |
| 05/03/2007 | DE102005051889A1 Kosmetische oder dermatologische Zubereitung zum Schutz vor Lichtalterung Cosmetic or dermatological composition for protection against photoaging |
| 05/03/2007 | DE102005047946A1 Verwendung von Aktivatoren der löslichen Guanylatzyklase zur Behandlung von akuten und chronischen Lungenkrankheiten Use of activators of soluble guanylate cyclase for the treatment of acute and chronic lung diseases |
| 05/03/2007 | DE102005038992A1 Agent, useful for killing single-cell organisms and for preparing medicaments for treating diseases caused by the organisms, comprises N-chlorotaurine in aqueous solution |
| 05/03/2007 | DE102005012873B4 Aminocarbonyl substituierte 8-N-Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Aminocarbonyl substituted 8-N-benzimidazoles, process for their preparation and their use as medicaments |
| 05/03/2007 | DE10065704B4 Verwendung einer Kombination aus Proteasen und einer Retinol-Quelle zur Bekämpfung der Hautalterung Using a combination of proteases and a retinol-source to combat skin aging |
| 05/03/2007 | CA2667944A1 Aromatic di-acid-containing poly (ester amide) polymers and methods of use |
| 05/03/2007 | CA2665717A1 Methods and compositions comprising a flightless i antagonist for modulating wound repair |
| 05/03/2007 | CA2632211A1 Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| 05/03/2007 | CA2631543A1 Skin care composition for accelerated production of collagen proteins and method of fabricating same |
| 05/03/2007 | CA2628790A1 Novel quinolizidine and octahydropyridopyrazine compounds |
| 05/03/2007 | CA2628074A1 Aminodihydrothiazine derivative |
| 05/03/2007 | CA2628015A1 Fixed ratio drug combination treatments for solid tumors |
| 05/03/2007 | CA2627757A1 Therapeutic compositions and methods |